Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Huu Tam D. Truong"'
Autor:
Huu Tam D, Truong, Kwan S, Lee
Publikováno v:
Cardiovascular Revascularization Medicine. 36:89-90
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db829371be56e0a518f08fe4ad9969fc
https://doi.org/10.1016/j.carrev.2021.12.019
https://doi.org/10.1016/j.carrev.2021.12.019
Autor:
Judit, Karacsonyi, Ehrin J, Armstrong, Huu Tam D, Truong, Ryan, Tsuda, Damianos G, Kokkinidis, Jose Roberto, Martinez-Parachini, Aya J, Alame, Barbara A, Danek, Aris, Karatasakis, Michele, Roesle, Houman, Khalili, Imre, Ungi, Subhash, Banerjee, Emmanouil S, Brilakis, Bavana V, Rangan
Publikováno v:
The Journal of invasive cardiology. 30(6)
The contemporary use and outcomes of excimer laser coronary atherectomy (ELCA) in percutaneous coronary intervention (PCI) are not well described.We examined the baseline clinical and angiographic characteristics and procedural outcomes of 130 target
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c967c5d07bd6ff564d86df87193d6e19
https://pubmed.ncbi.nlm.nih.gov/29543185
https://pubmed.ncbi.nlm.nih.gov/29543185
Autor:
Madhan Shanmugasundaram, Huu Tam D. Truong, Ranjith Shetty, Kapildeo Lotun, Divya Kapoor, Hoang M. Thai, Glenn Hunter
Publikováno v:
Cardiovascular revascularization medicine : including molecular interventions. 19(5 Pt)
Hemodynamic support with the Impella device is an important tool during high risk percutaneous coronary intervention. This device is usually inserted via the femoral artery. However, some patients have severe peripheral artery disease precluding the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eafa0ff7297d95f51d00c90e04c21f27
https://pubmed.ncbi.nlm.nih.gov/29422276
https://pubmed.ncbi.nlm.nih.gov/29422276
Publikováno v:
Cardiovascular Revascularization Medicine. 19:903-904
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::140985772b85934d143280dd1a71f76e
https://doi.org/10.1016/j.carrev.2018.10.006
https://doi.org/10.1016/j.carrev.2018.10.006
Autor:
Christine M. Bridgen, Huu Tam D. Truong, Harminder Sikand, Dan L. Ballard, Steven Rubino, Joseph Stein, Donna L. Agan, Judy E. Davidson
Publikováno v:
The Journal of cardiovascular nursing. 28(6)
BACKGROUND The American Heart Association/American College of Cardiology Foundation recommends monitoring for corrected QT (QTc) prolongation. The incidence of QTc prolongation in the general public is unknown. Episodic measurements may miss patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c2b8ac8b7e72e7f0556fa04a04ee0a1
https://pubmed.ncbi.nlm.nih.gov/22990234
https://pubmed.ncbi.nlm.nih.gov/22990234
Autor:
Davidson JE; Judy E. Davidson, DNP, RN, FCCM Director, Research Integration and Management, Scripps Clinical Research Center, La Jolla, California. Donna Agan, EdD Director of Operations Integration, Scripps Mercy Hospital, San Diego, California. Dan L. Ballard Jr, BS Process Validation Engineer, Welch Allyn Monitoring, Beaverton, Oregon. Huu Tam D. Truong, MD Cardiology Fellow, Cardiology Department, University of Arizona, Sarver Heart Center, Tucson. Christine M. Bridgen, PharmD Clinical Pharmacist, Department of Pharmacy, Scripps Encinitas Hospital, San Diego, California. Steven Rubino Network + Clinical Systems Specialist, Lead, Biomedical Engineering Department, Scripps Mercy Hospital, San Diego, California. Harminder Sikand, PharmD Clinical Director, Department of Pharmacy, Scripps Mercy Hospital, San Diego, California. Joseph Stein, MD, FACC Electrophysiologist, Division of Cardiology/Electrophysiology, Scripps Mercy Hospital, San Diego, California., Agan D, Ballard DL Jr, Truong HT, Bridgen CM, Rubino S, Sikand H, Stein J
Publikováno v:
The Journal of cardiovascular nursing [J Cardiovasc Nurs] 2013 Nov-Dec; Vol. 28 (6), pp. 584-90.